Dec 28, 2023
Join the experts for recent updates on estrogen
receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast
cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6
inhibitors.
Learning Objectives & Disclosures:
Dec 21, 2023
How equipped are you in taking a patient-first approach and prioritizing the needs of the patient and their caregivers?
Credit available for this activity expires: 12/19/24
Earn Credit / Learning Objectives & Disclosures: